Tumor promoter-stimulated phosphorylation of threonine 98 of the erbB protein of avian erythroblastosis virus (AEV) correlates with inhibition of erbB-dependent mitogenesis. To more clearly define the role of phosphorylation of this residue in regulation of the activity of the erbB protein, we have constructed erbB mutations which encode alanine (Ala-98), tyrosine (Tyr-98), or serine (Ser-98) at position 98. The biosynthesis and stability of the three mutant proteins were similar to those of the wild-type erbB protein, and all three retained the ability to transform chicken embryo fibroblasts. Treatment of transformed CEF with 12-tetradecanoylphorbol-13-acetate (TPA) stimulated incorporation of 32Pi into wild-type and mutant erbB proteins and resulted in a slight decrease in the electrophoretic mobilities of all the erbB proteins. Avian erythroblastosis virus (AEV) causes erythroblastosis and sarcomas in chickens (13) and transforms erythroblasts and fibroblasts in culture (11, 13). The erbB gene of AEV has been shown to be responsible for cellular transformation by AEV (11, 28) and encodes a protein related to the src gene tyrosine kinase family (29). The erbB protein shares extensive homology with the cytoplasmic domain of the epidermal growth factor (EGF) receptor (8). This region includes the tyrosine-specific protein kinase domain which appears to be responsible for the transmission of mitogenic signals by these proteins. For the EGF receptor, activation of this protein kinase requires ligand binding; however, the erbB protein lacks the ligand-binding domain and may be constitutively active.
Tumor promoter-stimulated phosphorylation of threonine 98 of the erbB protein of avian erythroblastosis virus (AEV) correlates with inhibition of erbB-dependent mitogenesis. To more clearly define the role of phosphorylation of this residue in regulation of the activity of the erbB protein, we have constructed erbB mutations which encode alanine (Ala-98), tyrosine (Tyr-98), or serine (Ser-98) at position 98. The biosynthesis and stability of the three mutant proteins were similar to those of the wild-type erbB protein, and all three retained the ability to transform chicken embryo fibroblasts. Treatment of transformed CEF with 12-tetradecanoylphorbol-13-acetate (TPA) stimulated incorporation of 32Pi into wild-type and mutant erbB proteins and resulted in a slight decrease in the electrophoretic mobilities of all the erbB proteins. Tryptic maps of erbB phosphopeptides showed no endogenous or TPA-stimulated phosphorylation of alanine 98 or tyrosine 98 in cells transformed by the Ala-98 and Tyr-98 mutants. Analysis of tryptic phosphopeptides by high-pressure liquid chromatography revealed that TPA treatment of cells stimulated phosphorylation of other sites of the erbB protein in addition to threonine 98. A high endogenous level of phosphorylation of serine 98 of the Ser-98 mutant protein was found, and TPA treatment of cells did not result in further phosphorylation of this residue. Cells transformed by wild-type and mutant AEV were equally sensitive to TPA-dependent inhibition of growth in soft agar and TPA-dependent inhibition of [3H]thymidine incorporation. TPA treatment inhibited tyrosine phosphorylation to a similar extent in cells transformed by wild-type or Ala-98 AEV. These data indicate that phosphorylation of threonine 98 of the erbB protein is not responsible for TPA-dependent inhibition of growth of AEV-transformed cells or TPA-induced inhibition of erbB-dependent tyrosine phosphorylation. TPA-stimulated phosphorylation of the erbB protein at other sites may mediate these effects. The data also show that subtle changes in a phosphorylation site (i.e., changing threonine to serine) can drastically alter recognition by protein kinases.
Avian erythroblastosis virus (AEV) causes erythroblastosis and sarcomas in chickens (13) and transforms erythroblasts and fibroblasts in culture (11, 13) . The erbB gene of AEV has been shown to be responsible for cellular transformation by AEV (11, 28) and encodes a protein related to the src gene tyrosine kinase family (29) . The erbB protein shares extensive homology with the cytoplasmic domain of the epidermal growth factor (EGF) receptor (8) . This region includes the tyrosine-specific protein kinase domain which appears to be responsible for the transmission of mitogenic signals by these proteins. For the EGF receptor, activation of this protein kinase requires ligand binding; however, the erbB protein lacks the ligand-binding domain and may be constitutively active.
The tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) has been shown to stimulate in vivo phosphorylation of threonine 654 of the EGF receptor (5, 17) and phosphorylation of an equivalent threonine residue of the erbB protein (7) . TPA-induced phosphorylation of the EGF receptor correlates with inhibition of both EGF binding (21) and inhibition of EGF receptor tyrosine kinase activity (4, 6, 10) . TPA also inhibits EGF-dependent mitogenesis in normal human fibroblasts (6), anchorage-independent growth of AEV-transformed chicken embryo fibroblasts (CEF) (7), EGF-stimulated Na+-H+ exchange (27) , EGF-dependent increases in intracellular Ca2+ in A431 cells (24) , and the effects of EGF on phosphatidylinositol metabolism (26) . These responses to TPA are probably mediated through activation of protein kinase C (3).
* Corresponding author.
Protein kinase C regulates the activity of a number of other receptor systems including those for ,-adrenergic agonists (20) , thrombin (30), oa1-adrenergic agonists (22) , and muscarinic agonists (19) . For some of these systems, phorbol esters induce receptor phosphorylation (22) , although it has not been shown conclusively that uncoupling of receptor function is a result of receptor phosphorylation.
To more clearly define the mechanisms involved in TPAdependent inhibition of growth of AEV-transformed CEF, we have examined the effects of site-directed mutagenesis of threonine 98 of the erbB protein from AEV Peptide synthesis and preparation of 32P-labeled peptide. The pentapeptide Lys-Arg-Ser-Leu-Arg was synthesized by the Rockefeller University Sequencing Facility. The peptide was purified by high-pressure liquid chromatography (HPLC) and phosphorylated by the catalytic subunit of the cAMP-dependent kinase (Sigma). The kinase reaction mixture contained 100 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES; pH 7.2), 10 mM MgCl2, 1 ,uM peptide, 1 ,uM [ot-32P]ATP (10 , uCi) , 0.5 mM phenymethylsulfonyl fluoride, and 1 U of kinase activity and was incubated at 24°C for 15 min. Phosphorylated peptide was isolated by thin-layer electrophoresis at pH 8.9 [1% (NH4)2CO3]. To generate the phosphopeptides Arg-PSerLeu-Arg and PSer-Leu-Arg, we incubated the pentapeptide with trypsin for various times and separated the two lessbasic species by electrophoresis at pH 8.9.
Tryptic peptide analysis by HPLC. The erbB proteins from 32P-labeled cells were immunoprecipitated, reduced, and carboxymethylated by the method of Cassel et al. (2) . The proteins were run on sodium dodecyl sulfate-gels, erbB bands were cut from the gels, and the gel slices were trypsin treated by the method of Gullick et al. (14) . The digests were loaded onto a C18 reverse-phase HPLC column equilibrated with 0.05% trifluoroacetic acid. Peptides were eluted with a gradient of 0 to 60% acetonitrile at 1 ml/min, and 1-ml fractions were collected and counted for Cerenkov radiation.
Phosphoamino acid analysis was performed by the method of (6). Two-dimensional peptide analysis, assay of soft-agar growth, and measurement of [3H]thymidine incorporation were performed as previously described (6, 7) . (Fig. 1) . Steady-state levels of the mature Mr 78,000 to 88,000 erbB protein were also unaffected by the mutations at position 98.
Since the biosynthesis of the erbB proteins appeared to be unaltered by the mutations, the effects of TPA on in vivo phosphorylation of the erbB proteins were examined (Fig.  2) . Figure 2A shows wild-type and mutant erbB proteins immunoprecipitated from 32P-labeled cells treated for 5 min with 100 ng of 4-a-phorbol per ml or with 25 ng of TPA per ml. TPA treatment caused an 80 to 120% increase in incorporation of 32p into all the erbB proteins. In addition, TPA treatment caused a slight decrease in the electrophoretic mobility of the erbB proteins.
As shown previously for the erbB protein from CEF transformed by the ES4 strain of AEV (7), TPA treatment of wild-type AEV-H-transformed CEF stimulated the phosphorylation of a basic phosphothreonine containing peptide (Fig. 2, panel B2, peptide z) . This phosphopeptide is identical to peptide z, which has been shown by Hunter et al. (17) to be phosphorylated at threonine 654 of the EGF receptor when A431 cells are treated with TPA (6; S. Decker, unpublished results). The sequence of this phosphopeptide is Lys-Arg-PThr-Leu-Arg, and it contains threonine 98 of the erbB protein. 6) ) and the peptides ArgPSer-Leu-Arg (y') and PSer-Leu-Arg (x') derived from it were subjected to two-dimensional thin-layer analysis as described in the text. (B) The respective synthetic phosphopeptides were mixed with the in vivo-phosphorylated peptides x, y, and z from the Ser-98 erbB protein as shown in Fig. 2B , panels 7 and 8. Equal counts of peptide x and peptide x' were mixed and run in two dimensions in panel 1, equal counts of peptide y and y' were used in panel 2, and equal counts of peptides z and z' were used in panel 3. About 300 cpm (Cerenkov radiation) was applied for each peptide. Electrophoresis was in the horizontal dimension (cathode to the left). The origins are marked with dots.
Ser-98 z peptide was almost identical to the mobility of peptide z from TPA-treated cells transformed with wild-type AEV. This suggested that replacement of threonine 98 with serine may have altered the accessibility of trypsin to basic residues in this region and resulted in the generation of three phosphopeptides containing serine at position 98 (PSer-LeuArg, Arg-PSer-Leu-Arg, and Lys-Arg-PSer-Leu-Arg). To examine this possibility, we eluted these three peptides from thin-layer plates and exhaustively retrypsinized them. This treatment had no effect on the mobility of peptide Ser-98 x but resulted in the loss of peptides Ser-98 y and Ser-98 z and the generation of phosphopeptides which comigrated with peptide Ser-98 x from these peptides (data not shown). To further substantiate the identity of these peptides, the peptide Lys-Arg-Ser-Leu-Arg was synthesized, 32P-labeled with cyclic AMP kinase catalytic subunit, and trypsinized. As expected, the phosphorylated peptide contained only phosphoserine, and trypsin treatment resulted in the appearance of two less-basic phosphorylated peptides presumed to be Arg-PSer-Leu-Arg and PSer-Leu-Arg. The positions of the tripeptide (labeled x'), the tetrapeptide (y'), and the pentapeptide (z'), in two-dimensional analysis are shown in Fig. 3 . Peptides x', y', and z' were mixed with peptides x, y, and z, respectively, from in vivo-labeled Ser-98-erbB protein (as in Fig. 2 , panels B7 and B8) and run in two dimensions. Peptides x and x' comigrated, as did peptides y and y' and peptides z and z' (Fig. 3B) . These data support the premise that Ser-98 x, Ser-98 y, and Ser-98 z form a set of related peptides containing phosphorylated serine 98. Since TPA stimulated the phosphorylation of the erbB proteins from the Ala-98 and Tyr-98 mutants, sites in the erbB protein other than threonine 98 must be phosphorylated. To more closely examine this possibility, erbB proteins from control and TPA-treated cells transformed by wild-type or Ala-98 AEV were trypsin treated, and resultant peptides were analyzed by reverse-phase HPLC with a C18 column (Fig. 4) . TPA treatment led to increased phosphorylation of several peptides. A phosphopeptide which eluted after about 4 min was found only in TPA-treated cells transformed by wild-type AEV. When this peptide was run in two-dimensional thin-layer analysis, it was found to comigrate with peptide z (Fig. 2, panel B2 ), indicating that it is the pentapeptide Lys-Arg-PThr-Leu-Arg, containing threonine 98 (data not shown). TPA treatment stimulated phosphorylation of other peptides from wild-type and Ala-98 erbB proteins, which eluted between 18 and 28 min, and phosphorylation of these peptides was stimulated to a similar extent in erbB proteins from wild-type and Ala-98 AEV.
The effects of TPA on the growth of wild-type AEV-and mutant AEV-transformed CEF were compared. All three mutant AEVs were judged to be comparable to wild-type AEV in terms of their ability to alter the cellular morphology of infected cells, to cause loss of contact inhibition in monolayer culture, and to induce formation of large colonies in soft agar. As previously shown for AEV-ES4-transformed CEF (7) , relatively low concentrations of TPA caused marked inhibition of soft-agar growth of AEV-H-transformed CEF ( Since phosphorylation of threonine 654 of the EGF receptor correlates with inhibition of receptor tyrosine kinase activity, we examined the effects of TPA treatment on phosphotyrosine levels in wild-type and Ala-98 AEV transformed CEF. Transformation by AEV-H resulted in an approximate twofold increase in whole-cell levels of phosphotyrosine (Table 3) . TPA treatment of cells for 2 h led to (5, 16, 18) . The growth-inhibitory effects of TPA on AEVtransformed cells may be mediated through phosphorylation of these additional sites or through some unknown mechanism not involving erbB phosphorylation. Use of the erbB mutants described in this study should facilitate identification of the additional TPA-induced phosphorylation sites in the erbB protein.
Surprisingly, considerable phosphorylation of serine 98 of the Ser-98 mutant erbB protein was found in normally growing cells. Protein kinase C is able to phosphorylate serine or threonine residues; however, there is no reason to believe that the threonine-to-serine mutation in the Ser-98 mutant would constitutively activate protein kinase C. The fact that the TPA still stimulates phosphorylation of the erbB protein in Ser-98-transformed cells supports this contention. Since many protein kinases recognize basic residues on the amino-and carboxy-terminal sides of phosphorylation sites, some other kinase may be responsible for serine 98 phosphorylation. Both the cyclic AMP-and cyclic GMP-dependent kinases require multiple basic residues on the aminoterminal side of a phosphorylation site and prefer serine to threonine (9) . On the basis of work with peptide substrates, a general cyclic AMP kinase recognition sequence of ArgArg-X-Ser-Y-has been determined (1) .
Serine 32 of histone H2B is preferentially phosphorylated by cyclic GMP-dependent kinase and is contained within the sequence Arg-Lys-Arg-Ser-Arg-Lys (15), a region similar to the sequence surrounding serine 98 in the Ser-98 erbB protein. Calmodulin-dependent kinase and phosphorylase kinase (9) , among others, also recognize basic residues in the vicinity of the phosphorylation site. On the basis of present knowledge of protein kinase sequence requirements and the data presented in this study, it is not possible to determine which protein kinase is responsible for constitutive phosphorylation of serine 98. It is interesting, however, that such a mutation can radically alter the phosphorylation state of a protein, and this suggests an approach for engineering specific changes in protein function. It would be of interest to examine the effects of substitution of serine at position 654 on the function of the EGF receptor.
